Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis

Appendix Figure 2. A probabilistic sensitivity analysis was conducted in which 129 critical parameters were simultaneously varied over probability distributions on the basis of published 95% CIs or other reasonable ranges. A cost-effectiveness ratio was computed for each of 1000 iterations for both targeted and universal screening of people age 55 years. QALY = quality-adjusted life-year.
Appendix Figure 2. A probabilistic sensitivity analysis was conducted in which 129 critical parameters were simultaneously varied over probability distributions on the basis of published 95% CIs or other reasonable ranges. A cost-effectiveness ratio was computed for each of 1000 iterations for both targeted and universal screening of people age 55 years. QALY = quality-adjusted life-year. Histograms of cost-effectiveness ratios resulting from probabilistic sensitivity analyses based on targeted (top) and universal (bottom) screening.

This Article

  1. Ann Intern Med May 4, 2004 vol. 140 no. 9 689-699
  1. AbstractFREE
  2. Figures
  3. Full Text
  4. Full Text (PDF)

Current Issue

  1. November 17, 2009, 151 (10)
  1. Alert me to current issues